Blue Jet Healthcare Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: ₹782.10 High: ₹814.00
on August 8, 2025

52 Week Range

Low: ₹454.85 High: ₹1,027.80
on August 16, 2024
on July 21, 2025

All-Time High: ₹1,027.80 on July 21, 2025

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR136.4B
EPS i 20.64
P/E Ratio (TTM) i 38.09
Forward P/E i 48.11
P/B Ratio i 12.03
PEG Ratio i 48.11
Div. Yield i 0.11%
ROE i 26.93%
Beta i N/A
Debt to Equity i 1.76

Financial Highlights

Profitability

Gross Margin i 48.44%
Operating Margin i 32.50%
Profit Margin i 29.35%

Returns and Earnings

Return on Assets (TTM) i 21.53%
Return on Equity (TTM) i 26.93%
EBITDA i INR5.0B
Net Income (TTM) i INR3.6B

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i INR70.44
Quarterly Revenue Growth (YoY) i 117.80%
Quarterly Earnings Growth (YoY) i 141.30%

Dividend Information

Last 12-Month Dividend i ₹1.00
Current Dividend Yield i 0.11%
3-Year Average Dividend Yield i 0.19%
3-Year Average Annual Dividend i ₹0.33
3-Year Total Dividends i ₹1.00
Ex-Dividend Date i September 17, 2024

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Blue Jet Healthcare BLUEJET 136.36B Mid-cap-3.34%-13.31%5.53%-5.20%34.90%63.78%99.82%99.82%
Biocon BIOCON 486.32B Large-cap-6.95%-2.12%5.11%-5.84%-1.25%8.09%17.05%-7.82%
OneSource Specialty ONESOURCE 217.07B Large-cap-5.06%-6.21%14.74%23.05%9.60%9.78%9.78%9.78%
Concord Biotech CONCORDBIO 170.64B Mid-cap-7.71%-7.37%16.79%-30.46%-24.09%4.99%73.01%73.01%
Supriya Lifescience SUPRIYA 53.24B Mid-cap0.08%-7.29%6.17%-14.46%-12.52%45.79%84.97%35.60%
Dishman Carbogen DCAL 37.57B Small-cap-5.74%-9.91%28.38%-2.24%-16.00%23.95%109.21%29.02%

Ownership & Short Interest

Insider Ownership i 86.00%
Institutional Ownership i 0.53%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 647K
Average 90-Day Volume i 775K

Blue Jet Healthcare Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Blue Jet Healthcare would have performed over time.

INR
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Blue Jet Healthcare reached a high of ₹1,027.80 (on July 21, 2025) and a low of ₹454.85 (on August 16, 2024).
Curious about Blue Jet Healthcare's size and valuation? Its market capitalization stands at 136.36B. When it comes to valuation, the P/E ratio (trailing twelve months) is 38.09, and the forward P/E (looking ahead) is 48.11.
Yes, Blue Jet Healthcare is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.11%, and the company has paid an average of ₹0.33 per share annually over the past 3 years.

When looking at Blue Jet Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Biocon
BIOCON
486.32BHealthcareBiotechnology8.09%17.05%
OneSource Specialty
ONESOURCE
217.07BHealthcareBiotechnology9.78%9.78%
Concord Biotech
CONCORDBIO
170.64BHealthcareBiotechnology4.99%73.01%
Supriya Lifescience
SUPRIYA
53.24BHealthcareBiotechnology45.79%84.97%
Dishman Carbogen
DCAL
37.57BHealthcareBiotechnology23.95%109.21%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Blue Jet Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 26.93%, the Debt to Equity ratio from the most recent quarter is 1.76, and its Gross Profit Margin stands at 48.44%.
Looking at Blue Jet Healthcare's growth, its revenue over the trailing twelve months (TTM) was INR12B. Compared to the same quarter last year (YoY), quarterly revenue grew by 117.80%, and quarterly earnings saw a YoY growth of 141.30%.
Wondering who owns Blue Jet Healthcare stock? Company insiders (like executives and directors) hold about 86.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.53%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.